Therapeutic Effects of Combination Tape in Knee Osteoarthritis

August 5, 2024 updated by: Osama Ragaa Abdelraouf Ibrahim, Batterjee Medical College

Combination Taping in Knee Osteoarthritis

Taping is a non-invasive technique that has been used for various musculoskeletal conditions, including knee OA. However, there is limited research on the effects of combination taping techniques on disability, functional capacity, and knee isokinetic torque in patients with knee OA.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Osteoarthritis (OA) is a common chronic condition, characterized by progressive loss of joint cartilage, leading to joint pain, stiffness, and functional disability. Knee OA is one of the most prevalent forms of OA, affecting millions of people worldwide. Various non-surgical treatment options have been reported, one of them is taping techniques. Combination taping is a unique treatment option, where two different types of taping is applied. However, there is limited research on the effects of combination taping techniques on disability, functional capacity, and knee isokinetic torque in patients with knee OA. So this study will be conducted to explore therapeutic effects in individuals who are suffering from knee OA

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Saudi Arabia
    • Makkah
      • Jeddah, Makkah, Saudi Arabia, 21442
        • Batterjee Medical college

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • second degree knee osteoarthritis

Exclusion Criteria:

  • Sever obesity, sever osteoarthritis, history of knee surgery, allergy to the tape

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: study group
Receive combination taping in addition to conventional physiotherapy
Other: Combination taping
Elastic and rigid tapes applied together for six weeks
Other Names:
  • conventional physiotherapy
Other: control group
Receive conventional physiotherapy
Other: Combination taping
Elastic and rigid tapes applied together for six weeks
Other Names:
  • conventional physiotherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: Nine weeks
Knee disability questionnaire
Nine weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 minute walk test
Time Frame: Nine weeks
Functional test
Nine weeks
Time up and go test
Time Frame: Nine weeks
Functional test
Nine weeks
Knee isokinetic torque
Time Frame: Nine weeks
Muscle strength
Nine weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Batterjee Medical College

Investigators

  • Principal Investigator: Osama R Ibrahim, PhD, BMC
  • Study Chair: Olfat M Ali, PhD, BMC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2023

Primary Completion (Actual)

November 27, 2023

Study Completion (Actual)

January 13, 2024

Study Registration Dates

First Submitted

February 23, 2023

First Submitted That Met QC Criteria

February 23, 2023

First Posted (Actual)

March 6, 2023

Study Record Updates

Last Update Posted (Actual)

August 6, 2024

Last Update Submitted That Met QC Criteria

August 5, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RES-2022-0230

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Available upon request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe